No, a CT scan is not required in this patient with known vestibular migraine presenting with typical symptoms and no red flags.
In a patient with established vestibular migraine on sumatriptan who presents with vertigo, headache, photophobia, and phonophobia but no focal neurological deficits or red-flag signs, imaging is unnecessary—the diagnosis is clinical and CT scanning would have extremely low yield while exposing the patient to unnecessary radiation and cost.
Clinical Reasoning
Why Imaging Is Not Indicated
The 2024 ACR Appropriateness Criteria explicitly state that "imaging is not required to diagnose vestibular migraine" 1. This patient's presentation is entirely consistent with their known diagnosis:
- Typical vestibular migraine features present: vertigo with headache, photophobia, and phonophobia 1
- No red flags: absence of focal neurological deficits, no thunderclap headache, no progressive symptoms, no fever, no neck stiffness, no altered consciousness 2
- Already on appropriate treatment: sumatriptan is established therapy for this patient 2
Diagnostic Yield of CT in This Context
Recent evidence demonstrates the futility of CT scanning in similar presentations:
- CT sensitivity for acute pathology is only 28.5% in vertigo patients, with specificity 98.9% 3
- In patients with vertigo and normal neurological exam, only 0.5% had acute pathology (infarction/hemorrhage) on CT, and all had cardiovascular risk factors 4
- Among 446 patients without hypertension, diabetes, or dyslipidemia presenting with isolated vertigo: 0% had acute findings 4
- Overall diagnostic yield is 6.9% for any clinically significant finding, and most are chronic/incidental 5
When to Consider Imaging
Imaging becomes appropriate only with atypical features or red flags:
Red Flags Requiring Imaging 2:
- Thunderclap headache (subarachnoid hemorrhage)
- Atypical aura (stroke, TIA)
- Progressive headache (mass lesion)
- Focal neurological symptoms
- New onset after age 50
- Fever with neck stiffness (meningitis)
- Altered consciousness or personality change
- Head trauma
Atypical Vestibular Features 1:
- Negative or atypical Dix-Hallpike testing when positional vertigo expected
- Lack of response to appropriate treatment maneuvers
- Continuous symptoms without episodic pattern
- Associated hearing loss or tinnitus (consider Menière's disease)
Management Approach
Since this patient has known vestibular migraine with typical symptoms and no concerning features:
- Continue current sumatriptan therapy for acute attacks 2, 6
- Assess attack frequency: If affecting quality of life on ≥2 days/month despite optimized acute therapy, consider preventive treatment 2
- Preventive options if needed: beta-blockers, antidepressants (amitriptyline), or antiepileptics (valproate) 2, 7, 8
- Avoid medication overuse: Counsel that frequent triptan use (>10 days/month) risks medication overuse headache 2, 6
Common Pitfalls to Avoid
- Over-imaging low-risk patients: CT has poor sensitivity (28.5%) and will miss most strokes if present; clinical assessment is more important 3
- Misinterpreting incidental findings: 38.9% of CTs show pathological findings, but only 6.9% are clinically significant 5
- Cost considerations: Each positive finding costs €1,576, with >90% of imaging showing no relevant pathology 9
- False reassurance: Normal CT does not rule out posterior circulation stroke in acute vestibular syndrome—MRI is superior (79.8% sensitivity) if stroke is genuinely suspected 3
If stroke becomes a concern (new focal deficits, high vascular risk, HINTS exam suggesting central cause), MRI brain is the appropriate test, not CT 1, 3.